Stock data
iBio, Inc. (IBIO)
iBio, Inc. (IBIO) reported revenue of US$0.10M and net income of -US$33.04M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-06-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$0.10M | — | -US$35.14M | -US$33.04M | — |
| 2025 | US$0.40M | — | -US$18.60M | -US$18.38M | — |
| 2024 | US$0.23M | — | -US$16.63M | -US$24.91M | — |
| 2023 | US$0.00M | — | -US$29.34M | -US$65.01M | — |
| 2022 | US$1.88M | US$2.17M | -US$29.70M | -US$50.30M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$10.60M | — |
| 2026-03-31 | — | -US$7.73M | — |
| 2025-12-31 | US$0.00M | -US$8.99M | — |
| 2025-09-30 | US$0.10M | -US$5.72M | — |
| 2025-06-30 | US$0.20M | -US$5.16M | — |
| 2025-03-31 | US$0.00M | -US$4.86M | — |
| 2024-12-31 | US$0.20M | -US$4.36M | — |
| 2024-09-30 | US$0.00M | -US$3.99M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.